Purchase Order 36C24623P0203

Cepheid Inc. was awarded a firm fixed-price purchase order valued at $570,182.92 by Veterans Integrated Service Network 6 (VISN 6), a civilian component of the Department of Veterans Affairs, for Cepheid service contract and service agreement work. The contract was awarded on February 10, 2023, with an ultimate completion date of February 9, 2027, and the place of performance is located in Fayetteville, North Carolina. This award carries no set-aside designation and represents a continuation of Cepheid's established role as a primary federal supplier of molecular diagnostic solutions to the VA healthcare system.

Cepheid, headquartered in Sunnyvale, California, specializes in advanced molecular diagnostic systems and reagents for detecting infectious diseases and clinical conditions. The company's primary offering to federal healthcare agencies is its GeneXpert diagnostic platform, which supports rapid molecular testing for COVID-19, influenza, respiratory syncytial virus, tuberculosis, and other infectious diseases. This purchase order falls under the larger framework of Cepheid's significant Indefinite Delivery Contract with VISN 6 valued at $32.8 million through September 30, 2030, which established the primary vehicle for Cepheid to supply molecular diagnostic testing system reagents, assays, and associated maintenance services across VISN 6 medical center laboratories. The VA's reliance on Cepheid across multiple Veterans Integrated Service Networks demonstrates the company's competitive positioning and critical role in supporting the department's clinical laboratory operations and infectious disease testing capabilities.